About: Identification of factors predicting the resistence of breast cancer with positive steroidal receptors to tamoxifen treatment     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Projekt, within Data Space : linked.opendata.cz associated with source document(s)

AttributesValues
rdf:type
rdfs:seeAlso
Description
  • To identify breast cancer resistant to tamoxifen treatment. Molecular markers which predict the rsistence to tamoxifen. Saving of money in adjuvant treatment of postmenopausal women. (en)
  • Identifikovat karcinomy prsu primárně rezistentní k léčbě tamoxifenem. Molekulární markry predikující rezistenci k tamoxifenu. Úspora financí v adjuvantní léčbě karcinomu prsu.
Title
  • Identification of factors predicting the resistence of breast cancer with positive steroidal receptors to tamoxifen treatment (en)
  • Identifikace faktorů predikujících rezistenci hormonálně závislých karcinomů prsu k terapii tamoxifenem
skos:notation
  • NR8270
http://linked.open...avai/cep/aktivita
http://linked.open...kovaStatniPodpora
http://linked.open...ep/celkoveNaklady
http://linked.open...datumDodatniDoRIV
http://linked.open...i/cep/druhSouteze
http://linked.open...ep/duvernostUdaju
http://linked.open.../cep/fazeProjektu
http://linked.open...ai/cep/hlavniObor
http://linked.open...hodnoceniProjektu
http://linked.open...vai/cep/kategorie
http://linked.open.../cep/klicovaSlova
  • breast cancer; tamoxifen; receptor; cyclin; hormonotherapy; mechanism of action; HER-2/neu; p53 (en)
http://linked.open...ep/partnetrHlavni
http://linked.open...inujicichPrijemcu
http://linked.open...cep/pocetPrijemcu
http://linked.open...ocetSpoluPrijemcu
http://linked.open.../pocetVysledkuRIV
http://linked.open...enychVysledkuVRIV
http://linked.open...lneniVMinulemRoce
http://linked.open.../prideleniPodpory
http://linked.open...iciPoslednihoRoku
http://linked.open...atUdajeProjZameru
http://linked.open.../vavai/cep/soutez
http://linked.open...usZobrazovaneFaze
http://linked.open...ai/cep/typPojektu
http://linked.open...ep/ukonceniReseni
http://linked.open...ep/zahajeniReseni
http://linked.open...jektu+dodavatelem
  • Solvers assess predictive markers of resist. only in relation to TMX. They point out at predic. import. of HER2 in relation to the horm. th.TMS. They deal with comparisons of symptomless survival of highly risky patients treated in adjuvance IA and TMX. (en)
  • Řešitelé hodnotí prediktivní markery rezistence pouze v souvislosti s TMX. Poukazují na predikativní význam HER2 ve vztahu k hormonální th. TMX. Zabývají se srovnáním bezpříznakového přežití u vysoce rizikových pacientek léčených v adjuvanci IA a TMX. (cs)
http://linked.open...tniCyklusProjektu
http://linked.open.../cep/klicoveSlovo
  • breast cancer
  • cyclin
  • mechanism of action
  • receptor
  • HER-2/neu
  • hormonotherapy
  • tamoxifen
is http://linked.open...vavai/riv/projekt of
is http://linked.open...vavai/cep/projekt of
Faceted Search & Find service v1.16.118 as of Jun 21 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 84 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software